vs

Side-by-side financial comparison of GDEV Inc. (GDEV) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $119.9M, roughly 1.9× GDEV Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 13.9%, a 5.5% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 13.3%).

GDEV Inc. is a gaming and entertainment holding company. It is a publicly traded company listed on the Nasdaq stock exchange, headquartered in Limassol, Cyprus. The holding was evolved in June 2023 from a video game company Nexters, founded in 2014, one of the top five independent mobile game companies in Europe. Subsidiaries of GDEV include Nexters Studio, which operates offices in Cyprus, Armenia, and Kazakhstan, as well as Cubic Games, Royal Ark, Game Gears and Light Hour Games. The compan...

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

GDEV vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.9× larger
ORGO
$225.6M
$119.9M
GDEV
Growing faster (revenue YoY)
ORGO
ORGO
+64.8% gap
ORGO
78.1%
13.3%
GDEV
Higher net margin
ORGO
ORGO
5.5% more per $
ORGO
19.4%
13.9%
GDEV

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
GDEV
GDEV
ORGO
ORGO
Revenue
$119.9M
$225.6M
Net Profit
$16.6M
$43.7M
Gross Margin
Operating Margin
15.5%
28.1%
Net Margin
13.9%
19.4%
Revenue YoY
13.3%
78.1%
Net Profit YoY
13.0%
469.5%
EPS (diluted)
$0.90
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GDEV
GDEV
ORGO
ORGO
Q4 25
$225.6M
Q3 25
$150.9M
Q2 25
$119.9M
$101.0M
Q1 25
$86.7M
Q4 24
$126.7M
Q3 24
$115.2M
Q2 24
$105.8M
$130.2M
Q1 24
$110.0M
Net Profit
GDEV
GDEV
ORGO
ORGO
Q4 25
$43.7M
Q3 25
$21.6M
Q2 25
$16.6M
$-9.4M
Q1 25
$-18.8M
Q4 24
$7.7M
Q3 24
$12.3M
Q2 24
$14.7M
$-17.0M
Q1 24
$-2.1M
Gross Margin
GDEV
GDEV
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Q1 24
73.9%
Operating Margin
GDEV
GDEV
ORGO
ORGO
Q4 25
28.1%
Q3 25
13.7%
Q2 25
15.5%
-12.5%
Q1 25
-30.9%
Q4 24
8.1%
Q3 24
5.4%
Q2 24
14.4%
-10.7%
Q1 24
-3.5%
Net Margin
GDEV
GDEV
ORGO
ORGO
Q4 25
19.4%
Q3 25
14.3%
Q2 25
13.9%
-9.3%
Q1 25
-21.7%
Q4 24
6.1%
Q3 24
10.7%
Q2 24
13.9%
-13.1%
Q1 24
-1.9%
EPS (diluted)
GDEV
GDEV
ORGO
ORGO
Q4 25
$0.31
Q3 25
$0.11
Q2 25
$0.90
$-0.10
Q1 25
$-0.17
Q4 24
$0.05
Q3 24
$0.09
Q2 24
$0.81
$-0.13
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GDEV
GDEV
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$41.6M
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-129.4M
$300.1M
Total Assets
$210.2M
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GDEV
GDEV
ORGO
ORGO
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$41.6M
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$50.8M
$89.9M
Q1 24
$88.6M
Total Debt
GDEV
GDEV
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
GDEV
GDEV
ORGO
ORGO
Q4 25
$300.1M
Q3 25
$255.1M
Q2 25
$-129.4M
$233.2M
Q1 25
$242.9M
Q4 24
$262.9M
Q3 24
$278.5M
Q2 24
$-118.7M
$263.5M
Q1 24
$278.0M
Total Assets
GDEV
GDEV
ORGO
ORGO
Q4 25
$598.7M
Q3 25
$509.8M
Q2 25
$210.2M
$461.1M
Q1 25
$467.4M
Q4 24
$497.9M
Q3 24
$446.3M
Q2 24
$282.8M
$443.2M
Q1 24
$458.5M
Debt / Equity
GDEV
GDEV
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GDEV
GDEV
ORGO
ORGO
Operating Cash FlowLast quarter
$39.4M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GDEV
GDEV
ORGO
ORGO
Q4 25
$39.4M
Q3 25
$3.1M
Q2 25
$-32.9M
Q1 25
$-19.9M
Q4 24
$10.9M
Q3 24
$8.7M
Q2 24
$4.7M
Q1 24
$-10.2M
Free Cash Flow
GDEV
GDEV
ORGO
ORGO
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
Q1 24
$-12.4M
FCF Margin
GDEV
GDEV
ORGO
ORGO
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Q1 24
-11.3%
Capex Intensity
GDEV
GDEV
ORGO
ORGO
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Q1 24
2.0%
Cash Conversion
GDEV
GDEV
ORGO
ORGO
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons